Materials (Jun 2019)

Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw

  • Siri Paulo,
  • Mafalda Laranjo,
  • Ana M. Abrantes,
  • João Casalta-Lopes,
  • Kathleen Santos,
  • Ana C. Gonçalves,
  • Anabela Baptista Paula,
  • Carlos Miguel Marto,
  • Ana Bela Sarmento-Ribeiro,
  • Eunice Carrilho,
  • Arménio Serra,
  • Maria F. Botelho,
  • Manuel M. Ferreira

DOI
https://doi.org/10.3390/ma12111840
Journal volume & issue
Vol. 12, no. 11
p. 1840

Abstract

Read online

(1) Background: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is one of the most often seen side effects in patients treated with nitrogen-containing bisphosphonates (BPs), a post-surgical non-healing wound condition. Since calcium phosphate (CP) compounds are able to adsorb zoledronate (ZOL) when used as a drug delivery vehicle, we aimed to verify if these ceramics might have a potential protective effect for soft tissues surrounding surgical osseous wounds. (2) Methods: The chemical reaction between ZOL and CP compounds was evaluated through ultraviolet-visible spectroscopy and elemental analysis. A primary culture of human gingival fibroblasts (HGF) was established as a model to evaluate the cytotoxicity of the association of ZOL (5−500 μM) and of ZOL/biphasic calcium phosphates (BCP). Metabolic activity, cell viability, types of cell death, the cell cycle through, and the migration ability of human gingival fibroblasts were evaluated. (3) Results: ZOL was adsorbed by biphasic calcium phosphate compounds in an aqueous solution. The HGF were sensitive to ZOL toxicity; nevertheless, ZOL/BCP showed a significant protective effect regarding metabolic activity, cell viability, and cell migration. (4) Conclusions: BCP interaction with ZOL reduces or abolishes its toxicity in HGF. This finding represents a potential solution for BRONJ in the case of patients undergoing therapy with ZOL.

Keywords